H1B Salary Data

Home › Employers › Cantor Fitzgerald & Co.

Cantor Fitzgerald & Co.: H-1B salaries and sponsorship

Cantor Fitzgerald & Co. filed 22 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 20. Median offered salary: $110,000.

Applications (LCAs)22
Certified20
Employer addressNew York, NY
H-1B dependent employerNo
Median offered salary$110,000
Middle half of salaries$100,000–$138,750
10th–90th percentile$100,000–$183,679

Does Cantor Fitzgerald & Co. sponsor H-1B visas?

Cantor Fitzgerald & Co. filed 22 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 4, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Analyst, Investment Banking5$105,000
Analyst, Technology Investment Banking4$105,000
AVP, Algo Quant Researcher2$110,000
Associate, Biotech Equity Research2$150,000
Director, Senior Biotech Analyst1$275,000
Investment Banking Analyst1$110,000
Analyst, Finance1$105,000
Associate - Healthcare1$175,000
Analyst, Power1$100,000
Analyst, Sales1$100,000
Associate, Investment Banking1$225,000
Associate1$135,000
Equity Research Associate1$179,088

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20246$107,500
FY20258$102,500
FY20268$142,500

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Equity Research Associate$179,088
Level IV
New York, NYJun 4, 2026Sep 18, 2026Certified
Analyst, Technology Investment Banking$125,000
Level I
New York, NYJun 2, 2026Jun 22, 2026Certified
Associate, Biotech Equity Research$150,000
Level I
New York, NYMay 21, 2026Oct 1, 2026Certified
Associate, Biotech Equity Research$150,000
Level II
New York, NYMay 21, 2026Oct 1, 2026Withdrawn
Associate$135,000
Level II
New York, NYApr 23, 2026May 4, 2026Certified
Associate, Investment Banking$225,000
H-1B1 (Singapore) · Level IV
New York, NYApr 21, 2026Apr 27, 2026Certified
AVP, Algo Quant Researcher$110,000
Level I
New York, NYFeb 6, 2026Feb 16, 2026Certified
AVP, Algo Quant Researcher$110,000
part-time · Level I
New York, NYFeb 4, 2026Feb 16, 2026Withdrawn
Analyst, Investment Banking$135,000
Level II
New York, NYSep 15, 2025Oct 1, 2025Certified
Analyst, Investment Banking$135,000
Level II
New York, NYSep 8, 2025Oct 1, 2025Certified
Analyst, Investment Banking$100,000
Level I
New York, NYJun 16, 2025Jun 30, 2025Certified
Analyst, Finance$105,000
Level I
New York, NYJun 13, 2025Oct 1, 2025Certified, then withdrawn
Associate - Healthcare$175,000
Level III
New York, NYMay 15, 2025Oct 1, 2025Certified
Analyst, Power$100,000
Level I
New York, NYMay 7, 2025Oct 1, 2025Certified
Analyst, Sales$100,000
Level I
New York, NYMay 7, 2025Oct 1, 2025Certified
Analyst, Technology Investment Banking$100,000
Level I
New York, NYMay 7, 2025Oct 1, 2025Certified
Director, Senior Biotech Analyst$275,000
Level IV
New York, NYSep 10, 2024Feb 17, 2025Certified
Investment Banking Analyst$110,000
Level I
New York, NYAug 14, 2024Aug 26, 2024Certified
Analyst, Investment Banking$105,000
Level I
New York, NYMay 22, 2024Oct 1, 2024Certified
Analyst, Investment Banking$100,000
Level I
New York, NYMay 22, 2024Oct 1, 2024Certified
Analyst, Technology Investment Banking$110,000
Level II
San Francisco, CAJan 31, 2024Feb 12, 2024Certified
Analyst, Technology Investment Banking$100,000
Level I
New York, NYJan 10, 2024Feb 5, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).